Δ
ALDH18A1 gene-related disorders
ADCL3
ARCL3A
Cutis laxa type III
Hereditary spastic paraplegia type 9
SPG9A
SPG9B
Journal
Journal of inherited metabolic disease
ISSN: 1573-2665
Titre abrégé: J Inherit Metab Dis
Pays: United States
ID NLM: 7910918
Informations de publication
Date de publication:
07 2020
07 2020
Historique:
received:
04
10
2019
revised:
13
01
2020
accepted:
30
01
2020
pubmed:
6
2
2020
medline:
24
8
2021
entrez:
5
2
2020
Statut:
ppublish
Résumé
The bifunctional homooligomeric enzyme Δ
Substances chimiques
Urea
8W8T17847W
ALDH18A1 protein, human
EC 1.2.1.3
Aldehyde Dehydrogenase
EC 1.2.1.3
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
657-670Informations de copyright
© 2020 SSIEM.
Références
Kamoun P, Aral B, Saudubray JM. A new inherited metabolic disease: Δ1-pyrroline 5-carboxylate synthetase deficiency. Bull Acad Natle Med. 1998;182:131-139.
Baumgartner MR, Hu CA, Almashanu S, et al. Hyperammonemia with reduced ornithine, citrulline, arginine and proline: a new inborn error caused by a mutation in the gene encoding Δ1-pyrroline-5-carboxylate synthase. Hum Mol Genet. 2000;9:2853-2858.
Baumgartner MR, Rabier D, Nassogne MC, et al. Δ1-pyrroline-5-carboxylate synthase deficiency: neurodegeneration, cataracts and connective tissue manifestations combined with hyperammonaemia and reduced ornithine, citrulline, arginine and proline. Eur J Pediatr. 2005;164:31-36.
Bicknell LS, Pitt J, Aftimos S, Ramadas R, Maw MA, Robertson SP. A missense mutation in ALDH18A1, encoding Δ1-pyrroline-5-carboxylate synthase (P5CS), causes an autosomal recessive neurocutaneous syndrome. Eur J Hum Genet. 2008;16:1176-1186.
Skidmore DL, Chitayat D, Morgan T, et al. Further expansion of the phenotypic spectrum associated with mutations in ALDH18A1, encoding Δ1-pyrroline-5-carboxylate synthase (P5CS). Am J Med Genet A. 2011;155A:1848-1856.
Zampatti S, Castori M, Fischer B, et al. De Barsy syndrome: a genetically heterogeneous autosomal recessive cutis laxa syndrome related to P5CS and PYCR1 dysfunction. Am J Med Genet A. 2012;158A:927-931.
Gardeitchik T, Mohamed M, Fischer B, et al. Clinical and biochemical features guiding the diagnostics in neurometabolic cutis laxa. Eur J Hum Genet. 2014;22:888-895.
Wolthuis DF, van Asbeck E, Mohamed M, et al. Cutis laxa, fat pads and retinopathy due to ALDH18A1 mutation and review of the literature. Eur J Paediatr Neurol. 2014;18:511-515.
Handley MT, Mégarbané A, Meynert AM, et al. Loss of ALDH18A1 function is associated with a cellular lipid droplet phenotype suggesting a link between autosomal recessive cutis laxa type 3A and Warburg micro syndrome. Mol Genet Genomic Med. 2014;2:319-325.
Fischer B, Callewaert B, Schröter P, et al. Severe congenital cutis laxa with cardiovascular manifestations due to homozygous deletions in ALDH18A1. Mol Genet Metab. 2014;112:310-316.
Stavropoulos DJ, Merico D, Jobling R, et al. Whole genome sequencing expands diagnostic utility and improves clinical management in pediatric medicine. NPJ Genom Med. 2016;1:15012.
Alazami AM, Al-Qattan SM, Faqeih E, et al. Expanding the clinical and genetic heterogeneity of hereditary disorders of connective tissue. Hum Genet. 2016;135:525-540.
Smigiel R, Kusmierska K, Pollak A, et al. Severe phenotype of De Barsy syndrome in two siblings with novel mutations in the ALDH18A1 gene. J Clin Med Genomics. 2017;5:1.
Lefebvre M, Beaufrere AM, Francannet C, et al. Extending the ALDH18A1 clinical spectrum to severe autosomal recessive fetal cutis laxa with corpus callosum agenesis. Am J Med Genet A. 2018;176:2509-2512.
Martinelli D, Häberle J, Rubio V, et al. Understanding pyrroline-5-carboxylate synthetase deficiency: clinical, molecular, functional, and expression studies, structure-based analysis, and novel therapy with arginine. J Inherit Metab Dis. 2012;35:761-776.
Fischer-Zirnsak B, Escande-Beillard N, Ganesh J, et al. Recurrent de novo mutations affecting residue Arg138 of pyrroline-5-carboxylate synthase cause a progeroid form of autosomal-dominant cutis laxa. Am J Hum Genet. 2015;97:483-492.
Nozaki F, Kusunoki T, Okamoto N, et al. ALDH18A1-related cutis laxa syndrome with cyclic vomiting. Brain Dev. 2016;38:678-684.
Bhola PT, Hartley T, Bareke E, et al. Autosomal dominant cutis laxa with progeroid features due to a novel, de novo mutation in ALDH18A1. J Hum Genet. 2017;62:661-663.
Coutelier M, Goizet C, Durr A, et al. Alteration of ornithine metabolism leads to dominant and recessive hereditary spastic paraplegia. Brain. 2015;138:2191-2205.
Panza E, Escamilla-Honrubia JM, Marco-Marín C, et al. ALDH18A1 gene mutations cause dominant spastic paraplegia SPG9: loss of function effect and plausibility of a dominant negative mechanism. Brain. 2016;139:e3.
Slavotinek AM, Pike M, Mills K, Hurst JA. Cataracts, motor system disorder, short stature, learning difficulties, and skeletal abnormalities: a new syndrome? Am J Med Genet. 1996;62:42-47.
Seri M, Cusano R, Forabosco P, et al. Genetic mapping to 10q23.3-q24.2, in a large Italian pedigree, of a new syndrome showing bilateral cataracts, gastroesophageal reflux, and spastic paraparesis with amyotrophy. Am J Hum Genet. 1999;64:586-593.
Kremer LS, Bader DM, Mertes C, et al. Genetic diagnosis of mendelian disorders via RNA sequencing. Nat Commun. 2017;8:15824.
Steenhof M, Kibaek M, Larsen MJ, et al. Compound heterozygous mutations in two different domains of ALDH18A1 do not affect the amino acid levels in a patient with hereditary spastic paraplegia. Neurogenetics. 2018;19:145-149.
Koh K, Ishiura H, Beppu M, et al. Novel mutations in the ALDH18A1 gene in complicated hereditary spastic paraplegia with cerebellar ataxia and cognitive impairment. J Hum Genet. 2018;63:1009-1013.
Magini P, Marco-Marin C, Escamilla-Honrubia JM, et al. P5CS expression study in a new family with ALDH18A1-associated hereditary spastic paraplegia SPG9. Ann Clin Transl Neurol. 2019;6:1533-1540.
Wei Q, Dong HL, Pan LY, et al. Clinical features and genetic spectrum in Chinese patients with recessive hereditary spastic paraplegia. Transl Neurodegener. 2019;8:19.
Valle D, Simell O. The hyperornithinemias. In: Scriver CR, Beaudet AL, Sly WS, et al., eds.The Metabolic and Molecular Bases of Inherited Disease, 8th. New York, NY: McGraw-Hill Medical; 2001:1857-1895.
Köhler ES, Sankaranarayanan S, van Ginneken CJ, et al. The human neonatal small intestine has the potential for arginine synthesis; developmental changes in the expression of arginine-synthesizing and -catabolizing enzymes. BMC Dev Biol. 2008;8:107.
van de Poll MC, Siroen MP, van Leeuwen PA, et al. Interorgan amino acid exchange in humans: consequences for arginine and citrulline metabolism. Am J Clin Nutr. 2007;85:167-172.
Hu CA, Lin WW, Obie C, Valle D. Molecular enzymology of mammalian Δ1-pyrroline-5-carboxylate synthase. Alternative splice donor utilization generates isoforms with different sensitivity to ornithine inhibition. J Biol Chem. 1999;274:6754-6762.
Hamano Y, Kodama H, Fujikawa Y, Tanaka Y, Nishimura K, Yanagisawa M. Use of immunocytochemical analysis of a duodenal biopsy specimen to identify a carrier of ornithine transcarbamylase deficiency. N Engl J Med. 1988;318:1521-1523.
Caldovic L, Morizono H, Gracia Panglao M, et al. Cloning and expression of the human N-acetylglutamate synthase gene. Biochem Biophys Res Commun. 2002;299:581-586.
Seddon AP, Zhao KY, Meister A. Activation of glutamate by gamma-glutamate kinase: formation of gamma-cis-cycloglutamyl phosphate, an analog of gamma-glutamyl phosphate. J Biol Chem. 1989;264:11326-11335.
Phang JM, Hu CA, Valle D. Disorders of proline and hydroxyproline metabolism. In: Scriver CR, Beaudet AL, Sly WS, et al., eds. The Metabolic and Molecular Bases of Inherited Disease. 8th ed. New York, NY: McGraw-Hill Medical; 2001:1821-1838.
Reversade B, Escande-Beillard N, Dimopoulou A, et al. Mutations in PYCR1 cause cutis laxa with progeroid features. Nat Genet. 2009;41:1016-1021.
Zaki MS, Bhat G, Sultan T, et al. PYCR2 mutations cause a lethal syndrome of microcephaly and failure to thrive. Ann Neurol. 2016;80:59-70.
Wu G, Bazer FW, Burghardt RC, et al. Proline and hydroxyproline metabolism: implications for animal and human nutrition. Amino Acids. 2011;40:1053-1063.
Kretz R, Bozorgmehr B, Kariminejad MH, et al. Defect in proline synthesis: pyrroline-5-carboxylate reductase 1 deficiency leads to a complex clinical phenotype with collagen and elastin abnormalities. J Inherit Metab Dis. 2011;34:731-739.
Kardos GR, Wastyk HC, Robertson GP. Disruption of proline synthesis in melanoma inhibits protein production mediated by the GCN2 pathway. Mol Cancer Res. 2015;13:1408-1420.
Sinnige PF, van Ravenswaaij-Arts CMA, Caruso P, et al. Imaging in cutis laxa syndrome caused by a dominant negative ALDH18A1 mutation, with hypotheses for intracranial vascular tortuosity and wide perivascular spaces. Eur J Paediatr Neurol. 2017;21:912-920.
Panza E, Martinelli D, Magini P, Dionisi Vici C, Seri M. Hereditary spastic paraplegia is a common phenotypic finding in ARG1 deficiency, P5CS deficiency and HHH syndrome: three inborn errors of metabolism caused by alteration of an interconnected pathway of glutamate and urea cycle metabolism. Front Neurol. 2019;10:131.
Olivieri G, Pro S, Diodato D, et al. Corticospinal tract damage in HHH syndrome: a metabolic cause of hereditary spastic paraplegia. Orphanet J Rare Dis. 2019;14:208.
Pendeville H, Carpino N, Marine JC, et al. The ornithine decarboxylase gene is essential for cell survival during early murine development. Mol Cell Biol. 2001;21:6549-6558.
Phang JM. Proline metabolism in cell regulation and cancer biology: recent advances and hypotheses. Antioxid Redox Signal. 2019;30:635-649.
Jukkola A, Kauppila S, Risteli L, et al. New lethal disease involving type I and III collagen defect resembling geroderma osteodysplastica, De Barsy syndrome, and Ehlers-Danlos syndrome IV. J Med Genet. 1998;35:513-518.
Marco-Marín C, Gil-Ortiz F, Pérez-Arellano I, Cervera J, Fita I, Rubio V. A novel two-domain architecture within the amino acid kinase enzyme family revealed by the crystal structure of Escherichia coli glutamate 5-kinase. J Mol Biol. 2007;367:1431-1446.